“Whoa! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Live discussion: Amyloid-ß degradation: The forgotten half of Alzheimer's disease

Journal of Alzheimer’s Disease 5 (2003) 491–497 IOS Press Discussion 1 Live Chat held 12 September 2002 with Wes Farris and Malcolm Leissring, Brigham and Women’s Hospital and Harvard Medical School. Posted 11 October 2002. Participants: Chastity Whitaker (Ohio State University), Chris Eckman (Mayo Clinic, Jacksonville), Claudia Almeida (Cornell University), Douglas Feinstein (University of Illinois, Chicago), Craig Atwood (Case Western Reserve University), Elizabeth Eckman (Mayo Clinic, Jacksonville), Keith Crutcher (University of Cincinnati), Lou Hersh (University of Kentucky), Malcolm Leissring (Harvard Medical School), Matthew LaVoie (Harvard Medical School), Nilufer Ertekin-Taner (Mayo Clinic, Jacksonville), Paul Shapiro (Elan Corporation), Reisuke Takahashi (Cornell University), Rina Yamin (Boston University School of Medicine), Stefan Mansourian (Harvard Medical ´ School), Steve Estus (University of Kentucky), Sylvain Lesn e (University of Caen, France), Tony Turner (Karolinski Institute, Stockholm, Sweden), Wes Farris (Harvard Medical School). Moderator: Gabrielle Strobel Malcolm Leissring and Wes Farris: We will start by discussing what genetic evidence there might be for the involvement of decreased amyloid-β (Aβ) degradation as a cause of Alzheimer’s disease (AD). Chris Eckman: Nilufer, this question may be best for you. Nilufer Ertekin-Taner: The main lines of genetic evidence, in my opinion, come from the mouse/rat knockout/mutant studies showing http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Alzheimer's Disease IOS Press

Loading next page...
 
/lp/ios-press/live-discussion-amyloid-degradation-the-forgotten-half-of-alzheimer-s-vgaYaGo6KC

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.